The Efficacy of Penicillins with β-lactamase Inhibitor or Cefmetazole against Pneumonia in which ESBL-Producing Bacteria were Isolated from Sputum

참고문헌 (6)

1. Eliel Nham, "Characteristics and Clinical Outcomes of Extended-Spectrum beta-lactamase-producing Klebsiella pneumoniae Bacteremia in Cancer Patients", Infection and Chemotherapy, 52(1), pp.59~69 (2020), 대한감염학회[DOI]
2. Benanti GE, "Carbapenem versus cefepime or piperacillin-tazobactam for empiric treatment of bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli in patients with hematologic malignancy", Antimicrob Agents Chemother, 63, pp.e01813~e01818 (2019)
3. Muhammed M, "Comparison between carbapenems and β-lactam", β-lactamase inhibitors in the treatment for bloodstream infections caused by extendedspectrum β-lactamase-producing Enterobacteriaceae: a systematic review and meta-analysis, 2017, pp.4, ofx099~
4. Fukuchi T, "Cefmetazole for bacteremia caused by ESBLproducing enterobacteriaceae comparing with carbapenems", BMC Infect Dis, 16, pp.427~ (2016)
5. Mandell LA, "Infectious Diseases Society of America", American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults, 2007, pp.44(Suppl 2), S27~S72
6. Vardakas KZ, "Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials", CMAJ, 179, pp.1269~1277 (2008)

관련 논문AI추천